M. Gutowski et al., Intraoperative immunophotodetection for radical resection of cancers: Evaluation in an experimental model, CLIN CANC R, 7(5), 2001, pp. 1142-1148
The aim of our study was to assess the technique of immunophotodetection (L
PD) in intraoperative situations in an experimental model and to determine
its capacity to detect very small tumor masses, TPD is a recent technology
involving fluorescent dye-labeled monoclonal antibodies (MAbs) directed aga
inst tumor-associated antigens. Up to now, no intraoperative device for TPD
has been developed, and limits of detection of the technique are unknown.
MAb-dye conjugates were prepared using the anti-carcinoembryonic antigen MA
b 35A7 labeled with indocyanine and I-125. Time-dependent (6, 12, 24, 48, a
nd 96 h post i.v. injection) and dose-dependent (10, 40, and 100 pg of conj
ugate) biodistribution studies were performed in nude mice bearing an LS174
T peritoneal carcinomatosis demonstrating high tumor uptake (up to 21% of t
he injected dose/g of tumor 48 h postinjection), Intraoperative IPD was stu
died, using a newly developed device, in 16 mice 48 h after i,v, injection
of 40 mug of the I-125-MAb 35A7-indocyanine conjugate, The fluorescent stat
us of 333 biopsies was compared with their histological analysis. Sensitivi
ty was 90.7%, specificity was 97.2%, the positive predictive value was 94.7
%, and the negative predictive value was 94.9%, Detection of very small nod
ules (<1 mg in weight or <1 mm in diameter) was possible. However, we obser
ved a decrease in sensitivity as a function of tumor mass: 100% for nodules
> 10 mg versus 78% for nodules less than or equal to1 mg, These experiment
s demonstrate that intraoperative TPD is easy to use and associated with hi
gh sensitivity and specificity, even for low tumor masses. On the basis of
these encouraging results, intraoperative IPD should be assessed in a clini
cal study.